DAP1, Negative Regulator Autophagy, Controls SubAB-Mediated
Apoptosis Autophagy
Kinnosuke Yahiro Hiroyasu Tsutsuki Kohei Ogura Sayaka Nagasawa b Joel Moss,c Masatoshi Nodaa
Departments Molecular Infectiologya Legal Medicine,b Graduate School Medicine, Chiba University, Chiba, Japan; Cardiovascular Pulmonary Branch,
National Heart, Lung, Blood Institute, National Institutes Health, Bethesda, Maryland, USAc

Autophagy apoptosis play critical roles cellular homeostasis survival. Subtilase cytotoxin (SubAB), produced non-
O157 type Shiga-toxigenic Escherichia coli (STEC), important virulence factor disease. SubAB, protease, cleaves spe-
cific site endoplasmic reticulum (ER) chaperone protein BiP/GRP78, leading ER stress, induces apoptosis. report HeLa cells, activation PERK (RNA-dependent protein kinase [PKR]-like ER kinase)-eIF2â?£ (â?£ subunit eu-
karyotic initiation factor 2)-dependent pathway SubAB-mediated BiP cleavage negatively regulates autophagy induces
apoptosis death-associated protein 1 (DAP1). SubAB treatment decreased amounts autophagy
markers LC3-II p62 mTOR (mammalian target rapamycin) signaling proteins ULK1 S6K. proteins showed increased expression levels PERK knockdown DAP1 knockdown cells. addition, depletion DAP1 HeLa cells dramatically inhibited SubAB-stimulated apoptotic pathway: SubAB-induced Bax/Bak conformational changes,
Bax/Bak oligomerization, cytochrome c release, activation caspases, poly(ADP-ribose) polymerase (PARP) cleavage. results DAP1 key regulator, PERK-eIF2â?£-dependent pathways, induction apoptosis reduction autophagy SubAB.



S    higa-toxigenic Escherichia coli (STEC) infection causes gastro-
     intestinal disease, including diarrhea, hemorrhagic colitis (1), hemolytic-uremic syndrome (HUS) (1â€“3). bacterial
                                                                                    bition lipopolysaccharide (LPS)-stimulated production
                                                                                    inhibition NF-â?¬B nuclear translocation inducible
                                                                                    nitric oxide synthase (iNOS) expression (21).
products Shiga toxins 1 2 important virulence factors                        Macroautophagy (referred autophagy) mediated pathogenesis disease (4). addition, subtilase cytotoxin                   autophagosomes, double-membrane vesicles enclose (SubAB) discovered STEC O113:H21 strain 98NK2,                         portion cytoplasm delivery lysosome. Autopha- responsible outbreak HUS (5). SubAB produced                       gosome formation dynamically regulated starvation primarily variety non-O157 serotypes STEC; STEC                          stresses involves complicated membrane reorganization
O157:H7, common serogroup implicated hemor-                             (22). Recent studies shown autophagy important
rhagic colitis HUS, produces SubAB (6â€“9).                          component innate defense variety infectious
SubAB enzymatically active subunit, subtilase-                    agents. Microorganisms,  evolved strategies like serine protease, receptor recognition domains,                  evading subverting host autophagy survive estab-
play important roles binding receptor target cell
                                                                                    lish persistent infections (23, 24). addition, negative
surface (5).
                                                                                    regulators autophagy (e.g., HO-1, Nrf2) (25â€“27). Death-asso-
    order understand SubAB cytotoxicity, investigated
                                                                                    ciated protein 1 (DAP1) identified novel substrate cultured cells.  observed SubAB bound sur-
                                                                                    mammalian target rapamycin (mTOR) negatively regu-
face receptors (e.g., Neu5Gc [10]), shown terminally sialic
acid modified membrane proteins (11, 12), translocated                      lates autophagy (28). DAP1 (15 kDa) initially identified target cells. endocytosed, SubAB transported                   role programmed cell death (29) shown ubiqui- Golgi apparatus, confirmed colocalization                   tously expressed types cells tissues (30). golgin-97, marker protein Golgi apparatus. SubAB                      molecular mechanisms involved SubAB-mediated delivered endoplasmic reticulum (ER) COG                       suppression generation autophagy marker LC3-II, 
served oligomeric Golgi)/Rab6/COPI (coat protein -dependent                       cluding reduced expression levels factors autophagy. ob-
pathway (13). ER, SubAB cleaves specific site Leu416                 served DAP1 key factor regulation SubAB-
endoplasmic reticulum chaperone BiP/GRP78 (14). SubAB                            induced apoptosis autophagy.
pendent BiP cleavage inhibited brefeldin (BFA), Golgi
complex-disrupting agent (15, 16). SubAB-induced ER stress BiP cleavage causes activation stress sensor proteins, fol-                      Received 16 June 2014 Returned modification 11 July 2014
lowed induction various cellular events leading cell                      Accepted 25 August 2014
damage, e.g., transient inhibition protein synthesis (17), G0/G1                    Published ahead print 2 September 2014
cell cycle arrest (15, 17), caspase-dependent apoptosis mito-                      Editor: B.  McCormick
chondrial membrane damage (18), activation Akt-NF-â?¬B sig-                           Address correspondence Kinnosuke Yahiro, yahirok@faculty.chiba-u.jp.
naling (19), downregulation gap junction expression (20), ac-                       Copyright Â© 2014, American Society Microbiology. Rights Reserved.
tivation RNA-dependent protein kinase (PKR)-like ER kinase                          doi:10.1128/IAI.02213-14
(PERK) followed caspase-dependent apoptosis (12), inhi-


November 2014 Volume 82 Number 11                                         Infection Immunity    p. 4899 â€“ 4908                                      iai.asm.org   4899
Yahiro et al.



MATERIALS METHODS                                                          Signal; Pierce). Bands visualized using LAS-1000 (Fujifilm).
Subtilase cytotoxin preparation. Escherichia coli producing recombinant        Densitometric analysis performed Image Gauge software (Fujif- tagged wild-type (wt) subtilase cytotoxin (SubAB) catalytically      ilm) scanned blots, protein levels normalized activated mutant (mt) SubAB  S272A alteration SubA)             â?£-tubulin GAPDH.
used source toxins purification according published             Immunofluorescence confocal microscopy. immunofluores-
procedure (17).                                                                cence analysis LC3B SQSTM1/p62, 1 â«» 105 HeLa cells micro-
    Antibodies reagents. Antibodies Atg5, Atg7, Atg12,       coverglass (Matsunami) incubated 200 ng/ml wt mt SubAB
Atg16L1, Beclin 1, DAP1, eIF2â?£, phospho-eIF2â?£(Ser51), LC3B, ULK1,              indicated times. Cells fixed 4  paraformaldehyde (PFA)
phospho-ULK1(Ser757), p70 S6 kinase (S6K), phospho-S6K(Thr389),                room temperature 15 min, washed twice PBS, imme-
cleaved caspase-7 (cCas7), cleaved poly(ADP-ribose) polymerase                 diately permeabilized ice-cold 100  methanol 10 min â«º20Â°C.
(cPARP), PERK, SQTMT1/p62, mTOR, phospho-mTOR(S2448)                       cells rinsed times PBS incubated block- purchased Cell Signaling. Mouse monoclonal antibodies                ing buffer (5  goat serum, 0.3  Triton X-100 PBS) room temper- BiP/GRP78 BD Biosciences, antibody           ature 1 h. visualize LC3B (D11; dilution, 1:200) SQSTM1/p62
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) Gene-                (D10E10; dilution, 1:400), cells incubated primary 
Tex. anti-LC3 monoclonal antibody (clone 1703) Cosmo              tibodies 0.4  bovine serum albumin (BSA)-PBS buffer 4Â°C 
Bio; Val-Ala-Asp-fluoromethylketone  VAD-FMK) R&D                 night, washed twice PBS, incubated DyLight 488-conju-
Systems; Necrostatin-1 anti-â?£-tubulin antibody Sig-          gated anti-mouse antibody (Rockland) Cy3-conjugated anti-rabbit
ma-Aldrich; 3-methyladenine (3-MA) MP Biomedicals;                antibody (Sigma) room temperature 1 h dark.                                                                                washes PBS, cells mounted glass slides using Prolong
bafilomycin A1 (Baf A1) cycloheximide Wako.
                                                                               Gold Antifade reagent 4=,6-diamidino-2-phenylindole (DAPI).
    Cell culture gene transfection. HeLa cells cultured Earleâ€™s
                                                                               stained cells visualized FV10i-LIV confocal microscopy
minimal essential medium (Sigma) containing 10  fetal calf serum
                                                                               (Olympus). images arranged Adobe Photoshop CS4.
(FCS). Cells plated 24 dishes (5 â«» 104 cells  12                                                                                    Statistics. P values densitometric analysis vacuolating
dishes (1 â«» 105 cells  medium containing 10  FCS. RNA inter-
                                                                               assays determined Studentâ€™s t test GraphPad Prism software
ference-mediated gene knockdown performed using validated Qia-
                                                                               (GraphPad, San Diego, CA). P values â¬?0.05 considered statisti-
gen HP small interfering RNAs (siRNAs) Atg12 (SI02655289)                                                                                cally significant.
PERK (SI02223718). Atg16L1 siRNA (5=-CAGGACAATGTGGATA
CTCAT-3=) designed validated described previously (31).
SQSTM1/p62 siRNAs (5=-GUAAGCCUAGGUGUUGUCATT-3=)                           RESULTS
designed validated described previously (32). DAP1 siRNAs          SubAB negatively regulates autophagy HeLa cells. 
purchased Dharmacon. Negative-control siRNAs purchased               stand relationship autophagy SubAB-induced Sigma-Aldrich. Cells transfected siRNAs 50 100 nM         apoptosis HeLa cells, examined effect SubAB 48 h using Lipofectamine RNAiMax transfection reagent (Invitro-         conversion LC3 expression level p62. Studies gen) according manufacturerâ€™s protocol. knockdown            shown autophagosome formation, level au-
target proteins confirmed immunoblotting. Myc-tagged
                                                                               tophagy marker LC3-II increased accumulated au-
hULK1 plasmid (33) obtained Addgene (plasmid 31961). HeLa
cells transfected X-tremeGENE HP DNA transfection reagent            tophagosomal membranes, level p62 decreased (Roche) according manufacturerâ€™s instruction manual.                    autophagosomes (35, 36). investigated effect     Cell viability assay. HeLa cells (1 â«» 104  incubated        SubAB HeLa cell viability, significantly decreased
wild-type catalytically inactive mutant SubAB (200 ng/ml)        48 h incubation wild-type (wt) SubAB, dicated times. Cell viability measured Cell Counting kit           catalytically inactive mutant (mt) SubAB (Fig. 1a). jindo) according manufacturerâ€™s instructions.                           SubAB-induced caspase-7 activation observed 3 h     Immunoprecipitation. Conformationally changed Bax Bak               incubation, amounts LC3-II p62 decreased coimmunoprecipitated described previously (34). Briefly, indicated      time-dependent manner (Fig. 1b). investigated effects
siRNA-transfected HeLa cells treated wt mt SubAB 3 h.         SubAB classical mTOR pathway HeLa cells. shown wash ice-cold phosphate-buffered saline (PBS), cells         Fig. 1c, wt SubAB, mt SubAB, induced BiP cleavage
solubilized lysis buffer {10 mM HEPES, 150 mM NaCl, 1.5 mM
                                                                               1 h. SubAB treatment 3 h suppressed ULK1 S6K
MgCl2, 1 mM EGTA, 2  3-[(3-cholamidopropyl)-dimethylammonio]-
1-propanesulfonate [CHAPS] [pH 7.4]} containing protease inhibitor
                                                                               expression. Previous studies shown ULK1 regulator
cocktail (Roche Diagnostics) incubated 30 min ice.       autophagy (33).  examined effect transient
centrifugation 17,400 â«» g 15 min 4Â°C, solubilized extracts (100      expression ULK1 HeLa cells inhibition LC3-II gen-
â?®g/200 â?®l) collected incubated conformation-spe-          eration SubAB. Compared control plasmid-transfected
cific anti-Bax (clone 3; BD Bioscience) anti-Bak (Ab-2; Calbiochem)         cells, ULK1 overexpression did inhibit suppression antibody 4Â°C 3 h. Immunoprecipitates collected incubation       LC3-II p62 SubAB (Fig. 1d).  investigated protein G-Sepharose (Invitrogen) 1 h, followed centrifugation      effect ULK1 overexpression SubAB-induced apoptosis. 1 min 4Â°C. immunocomplexes washed times           shown Fig. 1e, overexpression ULK1 did affect
lysis buffer, proteins dissolved SDS sample buffer, subjected       SubAB-induced PERK phosphorylation, eIF2â?£ phosphorylation,
SDS-PAGE 15  gels, transferred polyvinylidene difluoride             caspase-7 activation, PARP cleavage. data suggest (PVDF) membranes, analyzed Western blotting using
                                                                               SubAB functions independently ULK1.
anti-Bax anti-Bak antibodies (Cell Signaling).
    Immunoblot analysis. Cell lysis immunoblotting 
                                                                                   SubAB suppression autophagy required PERK 
formed described previously (12). Briefly, proteins separated       diated signaling. Previously, demonstrated SubAB induc-
SDS-PAGE transferred PVDF membranes, incu-              tion apoptosis BiP cleavage mediated ER stress
bated indicated primary antibodies. Detection performed           sensor protein PERK (12).  investigated horseradish peroxidase-labeled goat anti-mouse anti-rabbit sec-        PERK-related signaling pathways associated SubAB
ondary antibodies, followed enhanced chemiluminescence (Super               suppression autophagy HeLa cells. determined effects


4900    iai.asm.org                                                                                                                Infection Immunity
                                                                                                        DAP1 Controls SubAB-Regulated Apoptosis Autophagy




FIG 1 Effect SubAB autophagy HeLa cells.   HeLa cells incubated catalytically inactivated (mt) wild-type (wt) SubAB (200 ng/ml) 0,
3, 6, 24, 48 h. Cell viability SubAB determined Cell Counting kit described Materials Methods. Data means â«¾ standard deviations values experiments, duplicates experiment (n â«½ 6). *, P â¬? 0.05. (b) HeLa cells incubated mt wt SubAB (200 ng/ml) 0, 0.5, 1, 3 h.   Cell lysates analyzed Western blotting using indicated antibodies.   amounts LC3-II p62 incubation mt wt SubAB quantified densitometry. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (c) HeLa cells treated mt wt SubAB indicated times.   Cell lysates analyzed Western blotting using indicated antibodies.   amounts ULK1 S6K incubation mt wt SubAB quantified densitometry. Data means â«¾ standard deviations values experiments.
*, P â¬? 0.05. (d) Cells transiently expressing Myc-tagged ULK1 incubated mt wt SubAB 3 h 37Â°C.   amounts LC3-II, p62, ULK1 determined immunoblot analysis.   amounts LC3-II p62 incubation mt wt SubAB 3 h quantified densitometry. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (e) Cells transiently expressing ULK1 cDNAs treated mt wt SubAB 0, 1, 3 h 37Â°C. (Left) Cell lysates analyzed Western blotting using specific antibodies indicated. experiments repeated times similar results. (Right) amounts cCas7 cPARP incubation 3 h mt wt SubAB quantified densitometry.
Data means â«¾ standard deviations values experiments. *, P â¬? 0.05.


 SubAB mTOR-signaling pathway PERK knockdown                          PERK knockdown cells. control siRNA-transfected cells, cells. control siRNA-transfected cells, amounts phospho-                decreases LC3-II p62 levels SubAB inhibited mTOR, ULK1, phospho-ULK1, S6K, phospho-S6K, p62,                              Baf A1, prevents maturation autophagic vacuoles
LC3-II decreased SubAB. contrast, SubAB increased                      (37). PERK knockdown cells, amounts LC3-II p62 levels activation caspase-7. PERK knockdown cells,               decreased presence mt wt SubAB; 
expression level PERK significantly suppressed,                     significantly increased presence Baf A1 (Fig.
amounts ULK1, S6K, p62, LC3-II decreased                       2b). observed confocal microscopy, SubAB decreased presence SubAB. SubAB-induced caspase-7 activation sig-                number cells showing LC3-II, presence Baf A1
nificantly suppressed PERK knockdown cells, described previ-                (Fig. 2c, . contrast, PERK knockdown cells, basal
ously (12). catalytically inactive SubAB effect (Fig. 2a).             amounts LC3-II increased significantly sup-
    investigated effect bafilomycin A1 (Baf A1)                 pressed SubAB Baf A1 (Fig. 2c, . expression levels LC3-II p62 presence SubAB                     Previously, demonstrated SubAB-induced apoptosis 

November 2014 Volume 82 Number 11                                                                                                               iai.asm.org 4901
Yahiro et al.




FIG 2 PERK controls apoptosis autophagy SubAB HeLa cells.   Nontargeting control (NC) PERK siRNA-transfected HeLa cells incubated mt wt SubAB 3 h. NC, nontargeting control siRNA. (Left) Cell lysates analyzed Western blotting using specific antibodies indicated. (Right) amounts PERK, LC3-II, S6K, phospho-S6K (p-S6K), phospho-mTOR (p-mTOR), p62 incubation mt wt SubAB control (NC) PERK knockdown cells quantified densitometry. experiments repeated times similar results. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (b) siRNA-transfected HeLa cells incubated mt wt SubAB presence absence 100 nM
bafilomycin A1 (Baf A1) 3 h.   Cell lysates analyzed Western blotting using anti-LC3B, anti-p62, anti-BiP antibodies. Tubulin used loading control.   amounts LC3-II p62 quantified densitometry. experiments repeated times similar results. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (c)   indicated siRNA-transfected HeLa cells incubated mt wt SubAB presence absence 100 nM bafilomycin A1 (Baf A1) 3 h, followed fixation reaction indicated antibodies described Materials Methods.   LC3 puncta single cell manually counted confocal microscope (*, P â¬? 0.05). group,
30 cells randomly selected averaging number LC3 puncta cell.



caspase dependent (18). Recent studies shown apopto-                    p62. treatment 3-MA enhanced SubAB 
sis-mediated cleavage Beclin 1 Atg5 inhibits autophagy (38,                duced S6K dephosphorylation, 3-MA incubation did alter
39). investigated effect SubAB expression                SubAB-mediated BiP cleavage SubAB-suppressed LC3-II Atg5 Beclin 1 HeLa cells. SubAB treatment did alter                p62 expression (Fig. 3c, left). examine autophago-
amounts Atg5 Beclin 1 (Fig. 3a). examined                       formation involved SubAB-induced apoptosis, SubAB-induced caspase activation effect suppres-                    tested effect silencing Atg16L1 gene SubAB 
sion LC3-II p62. general caspase inhibitor, VAD-FMK,                   duced caspase activation. PERK knockdown dramatically sup-
completely suppressed SubAB-induced caspase-7 activation;                         pressed SubAB-induced activation caspase-7 cleavage  SubAB action resulting reduction LC3-II                    PARP. amounts LC3-II p62 decreased p62 expression affected.  SubAB did affect                SubAB PERK knockdown cells (Fig. 2). Knockdown Atg16L1
amounts Atg5 Beclin 1. necrosis inhibitor, Necrostatin,                  reduced basal levels LC3-II Atg5 proteins. 
did affect SubAB-induced reduction LC3-II p62 ex-                      SubAB-induced PARP cleavage caspase-7 activation pression (Fig. 3b).                                                               affected Atg16L1 knockdown. PERK Atg16L1 double-
    Furthermore, investigated effect 3-methyladenine                    knockdown cells, SubAB-induced PARP cleavage caspase-7
(3-MA), autophagy inhibitor, SubAB-suppressed LC3-II                        activation significantly increased levels mt


4902    iai.asm.org                                                                                                                        Infection Immunity
                                                                                                        DAP1 Controls SubAB-Regulated Apoptosis Autophagy




FIG 3 Effects SubAB autophagy-related proteins HeLa cells.   HeLa cells incubated mt wt SubAB 3 h. Cell lysates analyzed Western blotting using anti-Beclin1 anti-Atg5 antibodies. GAPDH used loading control. N.S., significant. (b) HeLa cells pretreated 10 â?®M VAD-FMK (VAD) 20 â?®M Necrostatin 1 (Necro) 30 min incubated mt wt SubAB 3 h. Cell lysates analyzed Western blotting using specific antibodies indicated. Cont, control. (c) HeLa cells preincubated 5 mM 3-methyladenine (3-MA) 30 min incubated mt wt SubAB 3 h. (Left) Cell lysates analyzed Western blotting using specific antibodies indicated. (Right) amounts LC3-II, p62, p-S6K quantified densitometry. experiments repeated times similar results. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (d e) indicated siRNA-transfected HeLa cells incubated mt wt SubAB 3 h. Cell lysates analyzed Western blotting using indicated antibodies. amounts cPARP cCas7 quantified densitometry. experiments repeated times similar results. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (f) NC, Atg12, Atg7 siRNA-transfected
HeLa cells incubated mt wt SubAB 3 h. (Left) Cell lysates analyzed Western blotting using specific antibodies indicated. experiments repeated times similar results. (Right) Atg7, Atg12, cCas7, cPARP obtained mt wt SubAB quantified densitometry. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05.


SubAB-treated cells (Fig. 3d). investigated effects                Fig. 3e, p62 knockdown did affect SubAB-induced PARP
p62 knockdown SubAB-induced apoptosis. p62, substrate                     cleavage caspase-7 activation. Taken  findings
autophagy, accumulated autophagy-defective conditions                    suggest autophagosome-related proteins (e.g., Atg16L1, p62) perturbs signal transduction pathways (36). shown                       affect SubAB-induced apoptosis.  investigated


November 2014 Volume 82 Number 11                                                                                                               iai.asm.org 4903
Yahiro et al.




FIG 4 Knockdown DAP1 rescues SubAB-mediated autophagy apoptosis.   Nontargeting control (NC) DAP1 siRNA-transfected HeLa cells (1 â«»
105  incubated mt wt SubAB (0.2 â?®g/ml) 3 4 h 37Â°C. (Left) Cell lysates analyzed Western blotting using indicated antibodies.
(Right) amounts DAP1, p62, LC3-II incubation mt wt SubAB NC DAP1 knockdown cells quantified densitometry. data representative results separate experiments. Data means â«¾ standard deviations values experiments. #, P â¬? 0.03; *,
P â¬? 0.05. (b) NC DAP1 siRNA-transfected cells incubated mt wt SubAB (0.2 â?®g/ml) 3 4 h 37Â°C. (Left) Cell lysates analyzed Western blotting using anti-cCas7 anti-cPARP antibodies. GAPDH used loading control. (Right) amounts cCas7 cPARP quantified densitometry. data representative results separate experiments. Data means â«¾ standard deviations values experiments. #, P â¬? 0.03; *, P â¬? 0.05. (c) NC DAP1 siRNA-transfected cells incubated wt mt SubAB 37Â°C 2 h, followed immunoblotting anti-p-eIF2â?£(Ser51), anti-eIF2â?£, anti-DAP1, anti-PERK antibodies. data representative results separate experiments. (d)
NC DAP1 siRNA-transfected cells incubated wt mt SubAB 37Â°C 3 4 h, followed immunoblotting specific antibodies indicated.
(e) (Left) siRNA-transfected cells incubated immunoblotted described panel d. (Right) amounts Atg5, Atg12, Atg16L1 incubation mt wt SubAB NC DAP1 knockdown cells quantified densitometry. data representative results separate experiments. Data means â«¾ standard deviations values experiments. *, P â¬? 0.05. (f) Cells pretreated indicated
concentrations rapamycin (Rapa) 1 h incubated mt wt SubAB 4 h, followed immunoblotting indicated antibodies. data representative results separate experiments.


 effect types Atg proteins, Atg12 Atg7,              siRNA. Depletion DAP1 did inhibit SubAB-mediated
SubAB-induced apoptosis. Knockdown Atg12, essen-                       BiP cleavage. control siRNA-transfected cells, SubAB treatment
tial autophagosome formation, did affect SubAB-induced                     3 h significantly decreased LC3-II p62 protein levels, PARP cleavage caspase activation.  Atg7 knockdown                       increased caspase-7 activation PARP cleavage. contrast,
significantly enhanced SubAB-induced apoptotic activity (Fig.                      DAP1 knockdown cells, basal level DAP1 decreased
3f), reported previously (40). results suggest Atg7                  SubAB treatment slightly decreased LC3-II p62 levels, participates autophagosome formation                    SubAB-induced caspase-7 activation PARP cleavage
volved apoptosis.                                                               significantly suppressed (Fig. 4a b). explore     Death-associated protein 1 (DAP1) plays important role                      DAP1 regulates PERK-eIF2â?£ signaling pathway, investi- SubAB-regulated apoptosis autophagy. Atg family                       gated, DAP1 knockdown cells, effect SubAB phospho-
proteins associated SubAB-regulated autophagy                        eIF2â?£. shown Fig. 4c, control cells, SubAB increased eIF2â?£ apoptosis, shown  examined role                        phosphorylation, inhibited DAP1 siRNA-trans-
DAP1, reported mTOR substrate                        fected cells. positive control, PERK knockdown cells,
negative regulator autophagy (28, 41), SubAB-regulated au-                   SubAB-induced eIF2â?£ phosphorylation suppressed. 
tophagy apoptosis.  investigated effect siRNA-                 DAP1 acts downstream SubAB-mediated BiP cleavage mediated knockdown DAP1 SubAB-associated apoptosis                           PERK-eIF2â?£ controls apoptosis autophagy. autophagy. DAP1 expression significantly suppressed                         explored effect DAP1 depletion mTOR sig-


4904    iai.asm.org                                                                                                                          Infection Immunity
                                                                                              DAP1 Controls SubAB-Regulated Apoptosis Autophagy



naling SubAB. previous study showed mTOR activity HeLa cells affected depletion DAP1 (28). shown Fig. 4d, SubAB treatment significantly decreased phospho-
ULK1 phospho-S6K levels DAP1 knockdown cells, effects
similar seen control siRNA-transfected cells, suggest-
ing effects independent DAP1.
    assessed effect DAP1 knockdown levels Atg proteins. shown Fig. 4e, control siRNA-transfected
cells, SubAB treatment slightly decreased Atg16L1.
Depletion DAP1 increased amounts Atg5, Atg12, Atg16L1, decreased SubAB.
     investigated effect rapamycin, mTOR com-
plex 1 (mTORC1) inhibitor (42), caspase activation SubAB. known rapamycin protective effects proapo-
ptotic insults (40). S6K phosphorylation suppressed rapa-
mycin dose-dependent manner. SubAB treatment decreased amounts LC3-II, p62, S6K; rapamycin did prevent
caspase-7 activation PARP cleavage SubAB (Fig. 4f). 
rapamycin did prevent proapoptotic effects SubAB.
    DAP1 regulates Bax/Bak conformational changes, Bax/Bak
oligomerization, cytochrome c release. DAP1 affected
SubAB-induced apoptosis negatively regulated autophagy shown  previous studies showed SubAB-induced apoptosis HeLa cells caused Bax/
Bak conformational changes cytochrome c release, followed           FIG 5 Depletion DAP1 inhibits SubAB-induced Bak/Bax conformational caspase activation (12, 43, 44). examined effect      changes.   NC DAP1 siRNA-transfected cells incubated mt transfection HeLa cells DAP1 siRNA SubAB              wt SubAB (0.2 â?®g/ml) 3 h 37Â°C. cells lysed, proteins                                                                         immunoprecipitated conformation-specific anti-Bax (cBax) anti-Bak
duced Bax/Bak conformational changes Bax/Bak oligomer-              (cBak) monoclonal antibodies described Materials Methods. ization using conformation-specific anti-Bax (cBax) anti-         immunocomplexes (IP) total-cell lysates (TCL) analyzed SDS-
Bak (cBak) monoclonal antibodies. monitored release         PAGE, followed immunoblotting anti-Bax anti-Bak antibodies. cytochrome c mitochondria cytosol. Silencing      (b) level cytochrome c (Cyt c) release cytoplasmic fraction                                                                         determined described Materials Methods. Cytochrome c tubulin
DAP1 gene did affect Bax Bak levels. Densitometric anal-        detected Western blotting. Conformationally changed Bax, conforma-
ysis showed SubAB-induced Bax/Bak conformational                   tionally changed Bak, Bax/Bak complexes, released Cyt c obtained mt
changes, Bax/Bak oligomerization, cytochrome c (Cyt c)           wt SubAB quantified densitometry. Data means â«¾ standard
lease dramatically reduced DAP1 knockdown cells            deviations values experiments. *, P â¬? 0.05. control siRNA-transfected cells (Fig. 5a b).
                                                                        suggesting SubAB-mediated inhibition autophagy DISCUSSION                                                              associated inactivation reduction Atg proteins 
Recent studies shown bacterial cytotoxins          clin 1 activation caspase.
duced autophagy, associated cell death (45â€“49).           SubAB toxin appears suppress basal levels
contrast, cyclic AMP (cAMP)-elevating toxins Bacillus           autophagy HeLa cells. results indicate SubAB
thracis Vibrio cholerae suppressed host autophagy       caused ER stress BiP cleavage, resulting activation suppressed immune responses modulated host cell physiol-            PERK-dependent pathway, leading cell damage cytotoxic
ogy (50). suggested toxins disrupt       response, suppression autophagosome formation. downstream step autophagosome formation (50).                inhibition observed PERK knockdown cells,  demonstrated cAMP-elevating toxins contribute         basal level LC3-II significantly increased.  PERK- increased bacterial replication (50). STEC infection,   dependent pathway involved SubAB-dependent 
known autophagy contributes pathogenesis. SubAB              crease autophagy. mainly non-O157, LEE-negative Stx2-producing                   Previous studies showed activation PERK/eIF2â?£/ATF4 STEC strains (51, 52). recent study showed Shiga toxins          unfolded protein response, leading inhibition mTORC1â€“
(Stxs), major virulence factors, induced autophagy         phospho-S6K signaling subsequent induction cytopro-
Stx-sensitive Stx-insensitive cells (46). showed Stx-       tective autophagy (53, 54). investigated effect induced LC3-II generation depended Stx B subunits, indicat-          SubAB mTORC1 signaling HeLa cells. SubAB treatment
ing toxin enzymatic activity required autophago-       decreased levels ULK1, S6K, phospho-ULK1, phospho- formation;  toxin activity sensitive cells           S6K. Knockdown PERK led increases basal levels involved caspase activation, leading Atg5 Beclin 1 cleav-     ULK1 S6K proteins, slightly reduced SubAB
age (46). treatment SubAB, amounts Atg5           treatment. addition, observed SubAB decreased LC3-II
Beclin 1 unaltered. Pretreatment general caspase         p62 protein levels ULK1-overexpressing cells. 
hibitor  VAD-FMK) necrosis inhibitor (Necrostatin) did           inhibition autophagosome formation SubAB independent prevent SubAB-induced reduction LC3-II p62 levels,           ULK1-signaling pathways.


November 2014 Volume 82 Number 11                                                                                                    iai.asm.org 4905
Yahiro et al.



    studies identified factors responsible neg-   eIF2â?£-dependent pathway, promote STEC infection
ative regulation autophagy (55). looked candidate pro-       participate pathogenesis severe disease.  teins serve negative regulators autophagy          showed DAP1 key regulator autophagy SubAB-treated cells. Interestingly, DAP1,       apoptosis cells intoxicated SubAB. Recent studies expressed ubiquitously types cells tissues (28),     shown DAP1 plays proapoptotic role human breast 
involved suppression autophagy SubAB          cer (59). Loss DAP1 colorectal cancer cells resulted gain
SubAB-induced apoptosis. DAP1 identified novel sub-           cellular migration loss sensitivity apoptosis induced
strate mTOR negatively regulates autophagy (28).          chemotherapeutic agent, 5-fluorouracil (5-FU) (60).   DAP1 shown positive mediator gamma           DAP1 plays critical roles cellular homeostasis survival. Fi-
interferon (IFN-â?¥)- tumor necrosis factor alpha (TNF-â?£)-           nally, understanding DAP1-related signaling compo-
induced programmed cell death (30, 56). Silencing DAP1          nent proteins help better characterize mTOR-independent
gene HeLa cells significantly inhibited reduction LC3-II     autophagy apoptosis. p62 expression seen SubAB, effects similar PERK knockdown. SubAB-induced phosphorylation eIF2â?£                 ACKNOWLEDGMENTS altered DAP1 depletion, suggesting DAP1            work supported Grant Aid Scientific Research downstream PERK-eIF2â?£. DAP1 knockdown did affect            Ministry Education, Science Culture Japan reduction mTOR-dependent S6K phosphorylation SubAB,              Improvement Research Environment Young Researchers program
suggesting DAP1 negatively regulate autophagy          Japan Science Technology Agency, grants aid
mTOR-independent pathway. Recent studies shown               Ministry Health, Labour, Welfare Japan (H24-Shinkou-
various factors, e.g., intracellular Ca2â«¹, cAMP, extracellular sig-    Ippan-012) Takeda Science Foundation. Joel Moss supported nal-regulated kinase (ERK), p38 mitogen-activated protein kinase       Intramural Research Program, National Institutes Health, National
(MAPK), reactive oxygen species (ROS), FoxO proteins, tran-        Heart, Lung, Blood Institute.
                                                                           acknowledge expert technical assistance K. Hirano.
scription factor EB (TFEB), involved induction au-
tophagy (57, 58). did observe effect ERK inhib-
                                                                       REFERENCES
itor (U0126) protein levels LC3-II p62                                                                         1. Riley LW, Remis RS, Helgerson SD, McGee HB, Wells JG, Davis BR,
activation caspase-7 SubAB DAP1 knockdown cells (data
                                                                           Hebert RJ, Olcott ES, Johnson LM, Hargrett NT, Blake PA, Cohen shown). results indicated ERK phosphorylation did           ML. 1983. Hemorrhagic colitis associated rare Escherichia coli participate suppression autophagy SubAB            serotype. N. Engl. J. Med. 308:681â€“ 685. http://dx.doi.org/10.1056/NEJM SubAB-induced apoptosis DAP1.              198303243081203.
levels proteins (e.g., ULK1, S6K) decreased        2. Latorre-Martinez JC, Garcia-Lozano T, Blanco J, Buesa J. 2007. Char-
                                                                           acterization Escherichia coli O157:H7 strains isolated sporadic
SubAB significantly increased DAP1 knockdown cells.                cases hemolytic-uremic syndrome children. Enferm. Infecc. Micro- proteins levels increased associated            biol. Clin. 25:603â€“ 604.  Spanish.) http://dx.doi.org/10.1157/13111190.
mTOR-independent control autophagy DAP1 play              3. Shiomi M, Togawa M. 1997. Sporadic cases hemolytic uremic syn- essential role reduction autophagy SubAB.                  drome hemorrhagic colitis serum IgM antibodies lipopolysac-
                                                                           charides enterohemorrhagic Escherichia coli O157. Nihon Rinsho 55:
    previous report showed DAP1 functionally silenced                                                                            686 â€“ 692.  Japanese.)
growing cells mTOR-dependent phosphorylation Ser3            4. Karmali MA. 2004. Prospects preventing systemic toxemic Ser51, dephosphorylated form DAP1 acting            complications Shiga toxin-producing Escherichia coli infections using
active form suppresses autophagy (28). investigate                 Shiga toxin receptor analogues. J. Infect. Dis. 189:355â€“359. http://dx.doi dephosphorylated form DAP1 activates inacti-             .org/10.1086/381130.
                                                                        5. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC. 2004. new
vates effects SubAB, FLAG-tagged DAP1, nonphos-            family potent AB5 cytotoxins produced Shiga toxigenic Escherichia
phorylated (S3A S51A) mutant DAP1, phosphomimetic                coli. J. Exp. Med. 200:35â€“ 46. http://dx.doi.org/10.1084/jem.20040392.
(S3D S51D) mutant DAP1 transiently transfected              6. Cergole-Novella MC, Nishimura LS, Dos Santos LF, Irino K, Vaz TM,
HeLa cells.  overexpressed DAP1 mutants did              Bergamini  Guth  2007. Distribution virulence profiles related
                                                                           new toxins putative adhesins Shiga toxin-producing Escherichia
alter SubAB-induced PARP cleavage wild-type
                                                                           coli isolated diverse sources Brazil. FEMS Microbiol. Lett. 274:
DAP1 (data shown).  findings suggest               329 â€“334. http://dx.doi.org/10.1111/j.1574-6968.2007.00856.x.
DAP1 phosphorylation sites participate SubAB-induced          7. Tozzoli R, Caprioli  Cappannella S, Michelacci V, Marziano ML,
apoptosis. DAP1 require phosphorylation sites              Morabito S. 2010. Production subtilase AB5 cytotoxin Shiga
unknown interaction factor participate SubAB-induced                 toxin-negative Escherichia coli. J. Clin. Microbiol. 48:178 â€“183. http://dx
                                                                           .doi.org/10.1128/JCM.01648-09.
apoptosis.                                                              8. Wu Y, Hinenoya  Taguchi T, Nagita  Shima K, Tsukamoto T,
     DAP1 required stimulation           Sugimoto N, Asakura M, Yamasaki S. 2010. Distribution virulence Bak/Bax-dependent apoptosis SubAB. SubAB-induced                  genes related adhesins toxins Shiga toxin-producing Escherichia
apoptosis, Bak/Bax conformational changes, Bak/Bax oligomer-               coli strains isolated healthy cattle diarrheal patients Japan. J.
                                                                           Vet. Med. Sci. 72:589 â€“597. http://dx.doi.org/10.1292/jvms.09-0557.
ization, cytochrome c release, leading activation                                                                         9. Buvens G, Lauwers S, Pierard D. 2010. Prevalence subtilase cytotoxin
caspases, regulated ubiquitin-proteasome pathway               verocytotoxin-producing Escherichia coli isolated humans (43, 44). Interestingly, sequence analysis DAP1 showed       raw meats Belgium. Eur. J. Clin. Microbiol. Infect. Dis. 29:1395â€“1399.
identical promyelocytic leukemia (PML)-interacting clone 1              http://dx.doi.org/10.1007/s10096-010-1014 
(PIC1) sentrin, Fas receptor-associated protein. pro-      10. Byres E, Paton AW, Paton JC, Lofling JC, Smith DF, Wilce MC, Talbot
                                                                           UM, Chong DC, Yu H, Huang S, Chen X, Varki NM, Varki  Rossjohn
teins share significant degree homology ubiquitin        J, Beddoe T. 2008. Incorporation non-human glycan mediates hu-
ubiquitin homology proteins (56). conclusion,             man susceptibility bacterial toxin. Nature 456:648 â€“ 652. http://dx.doi
SubAB suppression autophagy proceeded PERK-                   .org/10.1038/nature07428.



4906    iai.asm.org                                                                                                             Infection Immunity
                                                                                                          DAP1 Controls SubAB-Regulated Apoptosis Autophagy



11. Yahiro K, Satoh M, Morinaga N, Tsutsuki H, Ogura K, Nagasawa S,                      negatively regulates autophagy. Curr. Biol. 20:1093â€“1098. http://dx.doi
    Nomura F, Moss J, Noda M. 2011. Identification subtilase cytotoxin                .org/10.1016/j.cub.2010.04.041.
    (SubAB) receptors signaling, association SubAB-induced           29.   Levy-Strumpf N, Kimchi  1998. Death associated proteins (DAPs):
    BiP cleavage, responsible apoptosis HeLa cells. Infect. Immun.             gene identification analysis apoptotic tumor sup-
    79:617â€“ 627. http://dx.doi.org/10.1128/IAI.01020-10.                                 pressive functions. Oncogene 17:3331â€“3340.
12. Yahiro K, Tsutsuki H, Ogura K, Nagasawa S, Moss J, Noda M. 2012.               30.   Deiss LP, Feinstein E, Berissi H, Cohen O, Kimchi  1995. Identifica-
    Regulation subtilase cytotoxin-induced cell death RNA-                      tion novel serine/threonine kinase novel 15-kD protein po-
    dependent protein kinase-like endoplasmic reticulum kinase-dependent                 tential mediators gamma interferon-induced cell death. Genes Dev.
    proteasome pathway HeLa cells. Infect. Immun. 80:1803â€“1814. http:                 9:15â€“30. http://dx.doi.org/10.1101/gad.9.1.15.
    //dx.doi.org/10.1128/IAI.06164-11.                                             31.   Cooney R, Baker J, Brain O, Danis B, Pichulik T, Allan P, Ferguson DJ,
13. Smith RD, Willett R, Kudlyk T, Pokrovskaya  Paton AW, Paton JC,                    Campbell BJ, Jewell D, Simmons  2010. NOD2 stimulation induces
    Lupashin VV. 2009. COG complex, Rab6 COPI define novel Golgi               autophagy dendritic cells influencing bacterial handling antigen
    retrograde trafficking pathway exploited SubAB toxin. Traffic 10:         presentation. Nat. Med. 16:90 â€“97. http://dx.doi.org/10.1038/nm.2069.
    1502â€“1517. http://dx.doi.org/10.1111/j.1600-0854.2009.00965.x.                 32.   Pursiheimo JP, Rantanen K, Heikkinen PT, Johansen T, Jaakkola PM.
14. Paton AW, Beddoe T, Thorpe CM, Whisstock JC, Wilce MC, Rossjohn                      2009. Hypoxia-activated autophagy accelerates degradation SQSTM1/
    J, Talbot UM, Paton JC. 2006. AB5 subtilase cytotoxin inactivates                p62. Oncogene 28:334 â€“344. http://dx.doi.org/10.1038/onc.2008.392.
    endoplasmic reticulum chaperone BiP. Nature 443:548 â€“552. http://dx            33.   Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, Kundu M, Kim
    .doi.org/10.1038/nature05124.                                                        DH. 2009. ULK-Atg13-FIP200 complexes mediate mTOR signaling 15. Morinaga N, Yahiro K, Matsuura G, Moss J, Noda M. 2008. Subtilase                    autophagy machinery. Mol. Biol. Cell 20:1992â€“2003. http://dx.doi.org/10
    cytotoxin, produced Shiga-toxigenic Escherichia coli, transiently inhib-          .1091/mbc.E08-12-1249.
    protein synthesis Vero cells degradation BiP induces cell    34.   Mikhailov V, Mikhailova M, Degenhardt K, Venkatachalam MA, White E,
    cycle arrest G1 downregulation cyclin D1. Cell. Microbiol. 10:921â€“          Saikumar P. 2003. Association Bax Bak homo-oligomers mitochon-
    929. http://dx.doi.org/10.1111/j.1462-5822.2007.01094.x.                             dria. Bax requirement Bak reorganization cytochrome c release. J.
16. Chong DC, Paton JC, Thorpe CM, Paton AW. 2008. Clathrin-                             Biol. Chem. 278:5367â€“5376. http://dx.doi.org/10.1074/jbc.M203392200.
    dependent trafficking subtilase cytotoxin, novel AB5 toxin targets   35.   Mizushima N, Yoshimori T. 2007. interpret LC3 immunoblot-
    endoplasmic reticulum chaperone BiP. Cell. Microbiol. 10:795â€“ 806.               ting. Autophagy 3:542â€“545. http://dx.doi.org/10.4161/auto.4600.
    http://dx.doi.org/10.1111/j.1462-5822.2007.01085.x.                            36.   Pankiv S, Clausen TH, Lamark T, Brech  Bruun JA, Outzen H,
17. Morinaga N, Yahiro K, Matsuura G, Watanabe M, Nomura F, Moss J,                      Overvatn  Bjorkoy G, Johansen T. 2007. p62/SQSTM1 binds directly
    Noda M. 2007. distinct cytotoxic activities subtilase cytotoxin               Atg8/LC3 facilitate degradation ubiquitinated protein aggregates
    produced Shiga-toxigenic Escherichia coli. Infect. Immun. 75:488 â€“ 496.           autophagy. J. Biol. Chem. 282:24131â€“24145. http://dx.doi.org/10.1074
    http://dx.doi.org/10.1128/IAI.01336-06.                                              /jbc.M702824200.
18. Matsuura G, Morinaga N, Yahiro K, Komine R, Moss J, Yoshida H,                 37.   Klionsky DJ, Elazar  Seglen PO, Rubinsztein DC. 2008. Does bafilo-
    Noda M. 2009. Novel subtilase cytotoxin produced Shiga-toxigenic                  mycin A1 block fusion autophagosomes lysosomes? Au-
    Escherichia coli induces apoptosis Vero cells mitochondrial mem-              tophagy 4:849 â€“950. http://dx.doi.org/10.4161/auto.6845.
    brane damage. Infect. Immun. 77:2919 â€“2924. http://dx.doi.org/10.1128          38.   Wirawan E, Vande Walle L, Kersse K, Cornelis S, Claerhout S,
    /IAI.01510-08.                                                                       Vanoverberghe  Roelandt R, Rycke R, Verspurten J, Declercq W,
19. Yamazaki H, Hiramatsu N, Hayakawa K, Tagawa Y, Okamura M, Ogata                      Agostinis P, Vanden Berghe T, Lippens S, Vandenabeele P. 2010.
    R, Huang T, Nakajima S, Yao J, Paton AW, Paton JC, Kitamura M.                       Caspase-mediated cleavage Beclin-1 inactivates Beclin-1-induced au-
    2009. Activation Akt-NF-â?¬B pathway subtilase cytotoxin                     tophagy enhances apoptosis promoting release proapoptotic
    ATF6 branch unfolded protein response. J. Immunol.                factors mitochondria. Cell Death Dis. 1:e18. http://dx.doi.org/10
    183:1480 â€“1487. http://dx.doi.org/10.4049/jimmunol.0900017.                          .1038/cddis.2009.16.
20. Huang T, Wan Y, Zhu Y, Fang X, Hiramatsu N, Hayakawa K, Paton                  39.   Kang R, Zeh HJ, Lotze MT, Tang D. 2011. Beclin 1 network regulates
    AW, Paton JC, Kitamura M, Yao J. 2009. Downregulation gap junc-                   autophagy apoptosis. Cell Death Differ. 18:571â€“580. http://dx.doi.org
    tion expression function endoplasmic reticulum stress. J. Cell.               /10.1038/cdd.2010.191.
    Biochem. 107:973â€“983. http://dx.doi.org/10.1002/jcb.22202.                     40.   Ravikumar B, Berger  Vacher C, Oâ€™Kane CJ, Rubinsztein DC. 2006.
21. Tsutsuki H, Yahiro K, Suzuki K, Suto  Ogura K, Nagasawa S, Ihara                   Rapamycin pre-treatment protects apoptosis. Hum. Mol. Genet.
    H, Shimizu T, Nakajima H, Moss J, Noda M. 2012. Subtilase cytotoxin                  15:1209 â€“1216. http://dx.doi.org/10.1093/hmg/ddl036.
    enhances Escherichia coli survival macrophages suppression nitric     41.   Koren  Reem E, Kimchi  2010. Autophagy gets brake: DAP1, novel
    oxide production inhibition NF-â?¬B activation. Infect. Im-             mTOR substrate, activated suppress autophagic process. Au-
    mun. 80:3939 â€“3951. http://dx.doi.org/10.1128/IAI.00581-12.                          tophagy 6:1179 â€“1180. http://dx.doi.org/10.4161/auto.6.8.13338.
22. Mizushima N, Yoshimori T, Ohsumi Y. 2011. role Atg proteins          42.   Sabers CJ, Martin MM, Brunn GJ, Williams JM, Dumont FJ, Wieder-
    autophagosome formation. Annu. Rev. Cell Dev. Biol. 27:107â€“132. http:                recht G, Abraham RT. 1995. Isolation protein target FKBP12-
    //dx.doi.org/10.1146/annurev-cellbio-092910-154005.                                  rapamycin complex mammalian cells. J. Biol. Chem. 270:815â€“ 822.
23. Yuk JM, Yoshimori T, Jo EK. 2012. Autophagy bacterial infectious                 http://dx.doi.org/10.1074/jbc.270.2.815.
    diseases. Exp. Mol. Med. 44:99 â€“108. http://dx.doi.org/10.3858/emm.2012        43.   KL, Paton JC, Paton AW. 2010. Escherichia coli subtilase cytotoxin
    .44.2.032.                                                                           induces apoptosis regulated host Bcl-2 family proteins Bax/Bak. Infect.
24. Patel KK, Stappenbeck TS. 2013. Autophagy intestinal homeostasis.                Immun. 78:4691â€“ 4696. http://dx.doi.org/10.1128/IAI.00801-10.
    Annu. Rev. Physiol. 75:241â€“262. http://dx.doi.org/10.1146/annurev-physiol      44.   Yahiro K, Morinaga N, Moss J, Noda M. 2010. Subtilase cytotoxin
    -030212-183658.                                                                      induces apoptosis HeLa cells mitochondrial permeabilization 25. Rao VA, Klein SR, Bonar SJ, Zielonka J, Mizuno N, Dickey JS, Keller                  activation Bax/Bak, independent C/EBF-homologue protein
    PW, Joseph J, Kalyanaraman B, Shacter E. 2010. antioxidant tran-                 (CHOP), Ire1â?£ JNK signaling. Microb. Pathog. 49:153â€“163. http://dx
    scription factor Nrf2 negatively regulates autophagy growth arrest               .doi.org/10.1016/j.micpath.2010.05.007.
    induced anticancer redox agent mitoquinone. J. Biol. Chem. 285:         45.   LiÃ©vin-Le Moal V, Comenge Y, Ruby V, Amsellem R, Nicolas V, Servin
    34447â€“34459. http://dx.doi.org/10.1074/jbc.M110.133579.                              AL. 2011. Secreted autotransporter toxin (Sat) triggers autophagy epi-
26. Kim HP, Wang X, Chen ZH, Lee SJ, Huang MH, Wang Y, Ryter SW,                         thelial cells relies cell detachment. Cell. Microbiol. 13:992â€“1013.
    Choi  2008. Autophagic proteins regulate cigarette smoke-induced                  http://dx.doi.org/10.1111/j.1462-5822.2011.01595.x.
    apoptosis: protective role heme oxygenase-1. Autophagy 4:887â€“ 895.          46.    Lee MS, Cherla RP, Jenson MH, Leyva-Illades D, Martinez-
    http://dx.doi.org/10.4161/auto.6767.                                                 Moczygemba M, Tesh VL. 2011. Shiga toxins induce autophagy leading
27. Bolisetty S, Traylor  Kim J, Joseph R, Ricart K, Landar  Agarwal                differential signalling pathways toxin-sensitive toxin-resistant
     2010. Heme oxygenase-1 inhibits renal tubular macroautophagy                   human cells. Cell. Microbiol. 13:1479 â€“1496. http://dx.doi.org/10.1111/j
    acute kidney injury. J.  Soc. Nephrol. 21:1702â€“1712. http://dx.doi.org            .1462-5822.2011.01634.x.
    /10.1681/ASN.2010030238.                                                       47.   Gutierrez MG, Saka HA, Chinen  Zoppino FC, Yoshimori T, Bocco JL,
28. Koren  Reem E, Kimchi  2010. DAP1, novel substrate mTOR,                    Colombo MI. 2007. Protective role autophagy Vibrio cholerae



November 2014 Volume 82 Number 11                                                                                                                 iai.asm.org 4907
Yahiro et al.



      cytolysin, pore-forming toxin V. cholerae. Proc. Natl. Acad. Sci.               B, Zhang H, Cerniglia G, Bi M, Li Y, Gao Y, Liu H, Li C, Maity 
      U. S.  104:1829 â€“1834. http://dx.doi.org/10.1073/pnas.0601437104.                    Thomas-Tikhonenko  Perl AE, Koong  Fuchs SY, Diehl JA, Mills
48.   Di Venanzio G, Stepanenko TM, GarcÃ VÃ©scovi E. 2014. Serratia                         IG, Ruggero D, Koumenis C. 2012. ER stress-mediated autophagy pro-
      marcescens ShlA pore-forming toxin responsible early induction               motes Myc-dependent transformation tumor growth. J. Clin. Invest.
      autophagy host cells transcriptionally regulated RcsB. Infect.            122:4621â€“ 4634. http://dx.doi.org/10.1172/JCI62973.
      Immun. 82:3542â€“3554. http://dx.doi.org/10.1128/IAI.01682-14.                     55.   Liang C. 2010. Negative regulation autophagy. Cell Death Differ. 17:
49.   Terebiznik MR, Raju D, Vazquez CL, Torbricki K, Kulkarni R, Blanke                     1807â€“1815. http://dx.doi.org/10.1038/cdd.2010.115.
      SR, Yoshimori T, Colombo MI, Jones NL. 2009. Effect Helicobacter              56.   Liou ML, Liou HC. 1999. ubiquitin-homology protein, DAP-1, 
      pyloriâ€™s vacuolating cytotoxin autophagy pathway gastric epithe-             sociates tumor necrosis factor receptor (p60) death domain 
      lial cells. Autophagy 5:370 â€“379. http://dx.doi.org/10.4161/auto.5.3.7663.             duces apoptosis. J. Biol. Chem. 274:10145â€“10153. http://dx.doi.org/10
50.   Shahnazari S, Namolovan  Mogridge J, Kim PK, Brumell JH. 2011.                       .1074/jbc.274.15.10145.
      Bacterial toxins inhibit host cell autophagy cAMP generation.        57.   Lavallard VJ, Meijer AJ, Codogno P, Gual P. 2012. Autophagy, signaling
      Autophagy 7:957â€“965. http://dx.doi.org/10.4161/auto.7.9.16435.                         obesity. Pharmacol. Res. 66:513â€“525. http://dx.doi.org/10.1016/j
51.   Wolfson JJ, Jandhyala DM, Gorczyca LA, Qadeer  Manning SD,                           .phrs.2012.09.003.
      Hadler J, Rudrik JT, Thorpe CM. 2009. Prevalence operon encod-            58.   Ravikumar B, Futter M, Jahreiss L, Korolchuk VI, Lichtenberg M, Luo
      ing subtilase cytotoxin non-O157 Shiga toxin-producing Escherichia                  S, Massey DC, Menzies FM, Narayanan U, Renna M, Jimenez-Sanchez
      coli isolated humans United States. J. Clin. Microbiol. 47:                M, Sarkar S, Underwood B, Winslow  Rubinsztein DC. 2009. Mam-
      3058 â€“3059. http://dx.doi.org/10.1128/JCM.00706-09.                                    malian macroautophagy glance. J. Cell Sci. 122:1707â€“1711. http://dx
52.   Paton AW, Paton JC. 2005. Multiplex PCR direct detection Shiga                  .doi.org/10.1242/jcs.031773.
      toxigenic Escherichia coli strains producing novel subtilase cytotoxin. J.   59.   Wazir U, Jiang  Sharma AK, Mokbel K. 2012. mRNA expres-
      Clin. Microbiol. 43:2944 â€“2947. http://dx.doi.org/10.1128/JCM.43.6.2944                sion DAP1 human breast cancer: correlation clinicopathological
      -2947.2005.                                                                            parameters. Cancer Genomics Proteomics 9:199 â€“201.
53.   Avivar-Valderas  Bobrovnikova-Marjon E, Alan Diehl J, Bardeesy N,              60.   Jia Y, Ye L, Ji K, Toms  Davies ML, Ruge F, Ji J, Hargest R, Jiang
      Debnath J, Aguirre-Ghiso JA. 2013. Regulation autophagy                  